Therapeutic utility of immunosuppressive TREM2+ macrophages: an important step forward in potentiating the immune checkpoint inhibitors

Signal Transduct Target Ther. 2020 Nov 10;5(1):264. doi: 10.1038/s41392-020-00383-5.

Authors

Fulya Koksalar Alkan¹, Hasan Korkaya^{2

3}

Affiliations

¹ Research Institute for Health Sciences and Technologies, Istanbul Medipol University, Istanbul, Turkey.
² Research Institute for Health Sciences and Technologies, Istanbul Medipol University, Istanbul, Turkey. HKORKAYA@augusta.edu.
³ Georgia Cancer Center, Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, Augusta, GA, 30912, USA. HKORKAYA@augusta.edu.

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Immune Checkpoint Inhibitors*
Immunotherapy
Macrophages
Neoplasms* / drug therapy

Substances

Immune Checkpoint Inhibitors